Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
PLoS One. 2024 Nov 1;19(11):e0304961. doi: 10.1371/journal.pone.0304961. eCollection 2024.
C-reactive protein (CRP) and high-sensitivity C-reactive protein (hsCRP) are measures of inflammation used in diagnosis, to guide treatment decisions, and in disease prediction. Variability in measured CRP and hsCRP may affect their clinical utility but estimates of within-subject variability are based on limited data.
A systematic review and meta-analysis was performed to estimate longitudinal within-subject variability of CRP and hsCRP over any time period. Follow-up studies of any design in adults or children, with repeated measures of CRP or hsCRP were sought. Multiple databases were searched from inception to November 2022. Titles and abstracts were screened in duplicate. Full text screening and data extraction were performed by one reviewer and verified by a second. Risk of bias was assessed with a modified Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) tool. Intraclass correlation coefficient (ICC) results were pooled with a meta-analysis and coefficient of variation (CV) results were described by median and range.
Of 2675 studies identified, 60 met the inclusion criteria: 34 reported CRP and 26 reported hsCRP. For CRP, median CV was 0.41 (range 0.11 to 0.89), and the pooled estimate of ICC was 0.55 (95% CI 0.35 to 0.74). For hsCRP, median CV was 0.44 (range 0.27 to 0.76) and the pooled estimate of ICC was 0.62 (95% CI 0.58 to 0.67).
Assessment of variability was not the main aim of many of the included papers, and it is possible that some relevant papers have been missed. Many of the papers included had low numbers of participants and/or low numbers of repeated measurements.
Estimated within-subject variability is high for both CRP and hsCRP, but estimates are based on small numbers of participants and measurements. There is a need for better estimates of within-subject variability from analysis of larger numbers of repeated measurements in larger numbers of subjects.
C 反应蛋白(CRP)和高敏 C 反应蛋白(hsCRP)是用于诊断、指导治疗决策和疾病预测的炎症指标。测量 CRP 和 hsCRP 的变异性可能会影响其临床应用,但关于个体内变异性的估计值基于有限的数据。
我们进行了一项系统评价和荟萃分析,以估算任何时间段内 CRP 和 hsCRP 的纵向个体内变异性。研究对象为成年人或儿童,设计类型不限,研究需包含 CRP 或 hsCRP 的重复测量。从创建到 2022 年 11 月,我们在多个数据库中进行了检索。对标题和摘要进行了重复筛选。由一名评审员进行全文筛选和数据提取,由另一名评审员进行验证。使用改良的共识基础的健康测量仪器选择标准(COSMIN)工具评估偏倚风险。采用荟萃分析汇总了组内相关系数(ICC)结果,用中位数和范围描述变异系数(CV)结果。
在 2675 项研究中,有 60 项符合纳入标准:34 项报告 CRP,26 项报告 hsCRP。对于 CRP,CV 的中位数为 0.41(范围为 0.11 至 0.89),ICC 的汇总估计值为 0.55(95%CI 为 0.35 至 0.74)。对于 hsCRP,CV 的中位数为 0.44(范围为 0.27 至 0.76),ICC 的汇总估计值为 0.62(95%CI 为 0.58 至 0.67)。
许多纳入的研究并非主要评估变异性,因此可能遗漏了一些相关的研究。许多纳入的研究的参与者数量较少,或重复测量的次数较少。
CRP 和 hsCRP 的个体内变异性估计值较高,但这些估计值基于少数参与者和测量次数。需要对更多参与者的大量重复测量进行分析,以获得更好的个体内变异性估计值。